| |
| |
|
| Insider
Information: |
Dixon Wendy L |
| Relationship: |
|
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
212,843 |
|
|
Indirect Shares
|
1,543 |
|
|
| Direct
Value |
$6,592,532 |
|
|
|
Indirect Value
|
$68,988 |
|
|
| Total
Shares |
214,386 |
|
|
| Total
Value |
$6,661,519 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -13.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
CMO & Pres, Global Mar... |
2006-05-22 |
87,003 |
2006-05-22 |
1,543 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2022-03-31 |
17,768 |
2011-11-17 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director |
2014-07-02 |
0 |
2013-05-24 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director |
2022-06-14 |
53,124 |
2014-03-11 |
0 |
Premium* |
|
|
Bluebird Bio, Inc. |
BLUE |
Director |
2021-11-11 |
11,894 |
2016-06-02 |
0 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Director |
2020-06-29 |
5,000 |
|
0 |
Premium* |
|
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2024-03-15 |
38,054 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2020-06-29 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CMO & Pres, Global Marketing |
• – – |
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
70,000 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CMO & Pres, Global Marketing |
• – – |
2004-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,556 |
77,556 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CMO & Pres, Global Marketing |
• – – |
2005-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,778 |
83,858 |
|
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2013-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
3,580 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
7,160 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,160) |
0 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2016-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2017-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
2,000 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,000 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,520 |
11,907 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
4,000 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,282 |
14,061 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
|
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,653 |
5,653 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,104 |
42,704 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,923 |
16,801 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
|
– • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,109 |
8,762 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2021-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,241 |
11,894 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,578 |
46,878 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,585 |
53,124 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
|
– • – |
2022-12-16 |
4 |
A |
$1.50 |
$10,751 |
D/D |
7,167 |
16,216 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
|
– • – |
2023-03-16 |
4 |
A |
$1.67 |
$10,750 |
D/D |
6,437 |
22,653 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
|
– • – |
2022-06-17 |
4/A |
A |
$2.03 |
$10,040 |
D/D |
4,946 |
4,946 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
|
– • – |
2022-06-17 |
4 |
A |
$2.03 |
$8,242 |
D/D |
4,060 |
4,060 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
|
– • – |
2023-06-16 |
4 |
A |
$2.10 |
$10,750 |
D/D |
5,119 |
27,772 |
0 |
- |
|
81 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
